Literature DB >> 2435008

The impact of technology and improved perioperative management upon survival from carcinoma of the pancreas.

E Dunn.   

Abstract

A community hospital experience of 238 instances of carcinoma of the pancreas during a 23 year period has been reviewed to see if there has been any change in survival, hospital stay, morbidity and operative strategy during the two decades included in this study as a result of improved diagnostic modalities and perioperative management. The results of this review indicate an increasing incidence of carcinoma of the pancreas in the second half of the study but also document a large number of patients whose diagnosis has been unsuspected until autopsy. The mortality for palliative bypass procedures dropped significantly in the second half of the study and provided a mean survival time of 7.6 months for this group of patients, approximately twice that of patients explored without palliation. Resectional procedures showed a very significant drop in mortality rate in the second half of the study and were used more extensively. Mean survival time of patients undergoing resectional procedures was 18.3 months with two prolonged survivors out of 22 patients. Significant operative morbidity remains a major problem and the chief cause of protracted postoperative stay and did not diminish in the second half of this study. Complications were primarily technical in nature. With this in mind, consideration should be given to concentrating the experience in pancreatic resectional operations in the hands of a limited number of surgeons within any given community.

Entities:  

Mesh:

Year:  1987        PMID: 2435008

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  8 in total

Review 1.  Pancreatic cancer in 1988. Possibilities and probabilities.

Authors:  A L Warshaw; R S Swanson
Journal:  Ann Surg       Date:  1988-11       Impact factor: 12.969

2.  Surgery offers the best palliation for carcinoma of the pancreas.

Authors:  I S Bailey; J Keating; C D Johnson
Journal:  Ann R Coll Surg Engl       Date:  1991-07       Impact factor: 1.891

3.  Combined use of nuclear morphometry and DNA ploidy as prognostic indicators in nonresectable adenocarcinoma of the pancreas.

Authors:  S Linder; J Lindholm; U Falkmer; M Blåsjö; P Sundelin; A von Rosen
Journal:  Int J Pancreatol       Date:  1995-12

4.  Duodenal obstruction in advanced pancreatic carcinoma: how effective is gastroenterostomy in palliation?

Authors:  J Geoghegan; P V Delaney; T J Egan
Journal:  Ir J Med Sci       Date:  1990-07       Impact factor: 1.568

Review 5.  Overview of pancreatic cancer, 1989.

Authors:  I Cohn
Journal:  Int J Pancreatol       Date:  1990 Aug-Nov

6.  Is there a place for gastroenterostomy in patients with advanced cancer of the head of the pancreas?

Authors:  G P van der Schelling; R P van den Bosch; J H Klinkenbij; P G Mulder; J Jeekel
Journal:  World J Surg       Date:  1993 Jan-Feb       Impact factor: 3.352

7.  Morbidity and mortality after radical and palliative pancreatic cancer surgery. Risk factors influencing the short-term results.

Authors:  K E Bakkevold; B Kambestad
Journal:  Ann Surg       Date:  1993-04       Impact factor: 12.969

8.  Is preoperative angiography useful in patients with periampullary tumors?

Authors:  W C Dooley; J L Cameron; H A Pitt; K D Lillemoe; N C Yue; A C Venbrux
Journal:  Ann Surg       Date:  1990-06       Impact factor: 12.969

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.